Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer
K Furuse M Fukuoka M Kawahara 1999 Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer J Clin Oncol 17 2692 2699
Sequential vs concurrent chemotherapy and radiation therapy for inoperable non-small cell lung cancer (NSCLC): Analysis of failures in a phase III study (RTOG 94-10) (abstract)
R Komaki W Seiferheld W Curran 2000 Sequential vs concurrent chemotherapy and radiation therapy for inoperable non-small cell lung cancer (NSCLC): analysis of failures in a phase III study (RTOG 94-10) (abstract) Proc Am Soc Ther Radiat Oncol (ASTRO) 48 5A
Second-line, low-dose, weekly paclitaxel in patients with stage III/A/IV nonsmall cell lung carcinoma who fail first-line chemotherapy with carboplatin plus paclitaxel
MA Socinski MJ Schell K Bakri 2002 Second-line, low-dose, weekly paclitaxel in patients with stage III/A/IV nonsmall cell lung carcinoma who fail first-line chemotherapy with carboplatin plus paclitaxel Cancer 95 1265 1273
Second-line chemotherapy with irrinotecan and vinorelbine in stage IIIB and IV non-small-cell lung cancer: A phase II study
CM Gonzalez JM Aramendia E Salgado 2002 Second-line chemotherapy with irrinotecan and vinorelbine in stage IIIB and IV non-small-cell lung cancer: a phase II study Am J Clin Oncol 25 480 484
Weekly docetaxel as second-line chemotherapy in advanced non-small cell lung cancer: Phase II trial
M Serke N Schoenfeld R Loddenkemper 2004 Weekly docetaxel as second-line chemotherapy in advanced non-small cell lung cancer: phase II trial Anticancer Res 24 1211 1216
Changes in early and late radiation responses with altered dose fractionation:implications for dose-survival relationship
HD Thames HR Withers LJ Peters 1982 Changes in early and late radiation responses with altered dose fractionation:implications for dose-survival relationship Int J Radiat Oncol Biol Phys 8 219 226
Accelerated fractionation vs hyperfractionation: Rationales for several treatments per day
HD Thames LJ Peters HR Withers 1983 Accelerated fractionation vs hyperfractionation: rationales for several treatments per day Int J Radiat Oncol Biol Phys 9 127 138
Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: Patterns of fractionation study of radiobiology
HR Withers LJ Peters JMG Taylor 1995 Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: patterns of fractionation study of radiobiology Int J Radiat Oncol Biol Phys 33 563 568
Reirradiation for locally recurrent lung cancer previously treated with radiation therapy
Y Okamoto M Murakami E Yoden 2002 Reirradiation for locally recurrent lung cancer previously treated with radiation therapy Int J Radiat Oncol Biol Phys 52 390 396
The reirradiation of recurrent bronchogenic carcinoma with external beam irradiation
JF Montebello BS Aron AK Manatunga 1993 The reirradiation of recurrent bronchogenic carcinoma with external beam irradiation Am J Clin Oncol 16 482 488
Thoracic reirradiation for symptomatic relief after prior radiotherapeutic management for lung cancer
EL Gressen M Werner-Wasik J Cohn 2000 Thoracic reirradiation for symptomatic relief after prior radiotherapeutic management for lung cancer Am J Clin Oncol 23 160 163